Manikandan Periyasamy

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Correction: Low Dose Iron Treatments Induce a DNA Damage Response in Human Endothelial Cells within Minutes.

Correction: Low Dose Iron Treatments Induce a DNA Damage Response in Human Endothelial Cells within Minutes.

Journal: PloS one
Published: December 19, 2024

Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast Cancer.

Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast Cancer.

Journal: Cancer research
Published: January 03, 2024

Induction of APOBEC3-mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancer.

Induction of APOBEC3-mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancer.

Journal: Oncogene
Published: December 10, 2021

Correction to: KSR1 regulates BRCA1 degradation and inhibits breast cancer growth.

Correction to: KSR1 regulates BRCA1 degradation and inhibits breast cancer growth.

Journal: Oncogene
Published: April 23, 2021

Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-κB.

Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-κB.

Journal: Oncogene
Published: September 01, 2020

Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion.

Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion.

Journal: Nature communications
Published: August 08, 2019

Endonuclease FEN1 Coregulates ERα Activity and Provides a Novel Drug Interface in Tamoxifen-Resistant Breast Cancer.

Endonuclease FEN1 Coregulates ERα Activity and Provides a Novel Drug Interface in Tamoxifen-Resistant Breast Cancer.

Journal: Cancer research
Published: July 17, 2019

p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells.

p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells.

Journal: Nucleic acids research
Published: May 17, 2017

ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment.

ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment.

Journal: Molecular cancer therapeutics
Published: December 07, 2016

Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer.

Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer.

Journal: Oncogene
Published: June 03, 2016

Low Dose Iron Treatments Induce a DNA Damage Response in Human Endothelial Cells within Minutes.

Low Dose Iron Treatments Induce a DNA Damage Response in Human Endothelial Cells within Minutes.

Journal: PloS one
Published: October 31, 2015

APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer.

APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer.

Journal: Cell reports
Published: May 14, 2015
Showing 1-12 of 19

Last Updated: 09/26/2026